Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia

May 2007

Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia.

But the ingredient in Invega is not really new...it's the active metabolite of risperidone (Risperdal).

Expect Invega to work as well as risperidone, and have similar side effects such as restlessness or extrapyramidal symptoms.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote